Suboxone

Suboxone is the buprenorphine-and-naloxone film that treats opioid addiction — and it works. Here's how it's taken, why precipitated withdrawal happens (and how to avoid it), and how to start.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What Is Suboxone?

Suboxone is the brand name for a combination of two medicines in one strip — buprenorphine and naloxone — used to treat opioid use disorder. The buprenorphine is the part that does the work, easing cravings and withdrawal; the naloxone is an abuse-deterrent that mostly comes along for the ride. Taken as directed, it is one of the most effective treatments there is for getting off opioids and staying off[1].

This is a treatment that works, and works well. People on it stop using illicit opioids, stay in care, and are far less likely to die of an overdose[2]. The one part that scares people most — the first dose, and the fear of being thrown into withdrawal — is also the part a clinician is trained to time so it doesn’t happen.

Starting Suboxone, or worried about an overdose? Here's what to do right now. Call 988 if you're in danger.
If you’re in danger right now or thinking about suicide, call or text 988 (Suicide & Crisis Lifeline), any time.

What to do:

  • If someone is overdosing on opioids — slow or stopped breathing, blue lips, can’t be woken — call 911 and give naloxone (Narcan) now. Suboxone itself is far safer than other opioids, but it is still an opioid, and mixing it with benzodiazepines or alcohol can stop breathing.
  • Never use alone, and keep naloxone nearby. Most opioid deaths happen when no one is there to call for help.
  • If you’re afraid to start because of withdrawal, that fear is manageable. Starting Suboxone the right way — in mild-to-moderate withdrawal, on a clinician’s timing — is what keeps it from going wrong. Find treatment that fits your life →

Find treatment today →

AddictionHelp.com Fast Facts
  • Suboxone is buprenorphine plus naloxone, and it’s a first-line treatment for opioid use disorder — the buprenorphine treats the addiction, the naloxone is there to deter misuse[1].
  • It cuts the risk of dying: buprenorphine reduces illicit opioid use, overdose, and all-cause mortality in people with opioid use disorder[2].
  • The naloxone is inert when you take it correctly — it’s poorly absorbed under the tongue and only causes problems if the strip is misused by injection[3].
  • Precipitated withdrawal is the main fear, and it’s far rarer than its reputation — a systematic review found a low rate of it, even among people using fentanyl[4].
  • A regular doctor can prescribe it now — buprenorphine is delivered in ordinary office-based and primary care settings, not only specialty clinics[5].

Why Suboxone Combines Buprenorphine and Naloxone

What Suboxone actually isSuboxone is a fixed combination of buprenorphine (the active medicine that treats opioid use disorder) and naloxone (an opioid blocker added only to discourage misuse). Dissolved under the tongue, the naloxone barely registers — its whole job is to ruin the strip for anyone who tries to inject it.

Suboxone is not a single drug. It is a deliberate pairing, and understanding why the two are together explains almost everything distinctive about it.

The buprenorphine is the treatment. It quiets cravings and holds off withdrawal, and the deep pharmacology of how it does that — the partial-agonist action, the ceiling that makes it so much safer than other opioids — is shared by every buprenorphine product. For that full mechanism, see how buprenorphine works →. Suboxone’s distinguishing feature is the second ingredient.

The Naloxone Is an Abuse Deterrent, Not the Treatment

Naloxone is the same medicine in Narcan — an opioid blocker. In Suboxone it is included for one reason: to make the strip hard to misuse. Taken correctly under the tongue, the naloxone is barely absorbed and has little effect, so it doesn’t interfere with treatment[3]. The buprenorphine is what reaches your system and does the job.

The naloxone only matters if someone tries to misuse the strip — by dissolving and injecting it. Injected, the naloxone becomes active and can throw the person into sudden withdrawal, which removes the appeal of shooting it. That built-in deterrent is exactly why guidelines favor the combination product as a first-line choice: it carries the superior safety profile of buprenorphine with a lower potential for diversion and misuse, which also makes it suitable for flexible take-home dosing[6][7].

The naloxone, in other words, is a lock rather than a medicine. It does nothing useful when the strip is taken as directed, but it makes the product far less attractive to inject — which is why the combination became the everyday, take-home form of buprenorphine.

Suboxone Comes as a Film that Dissolves in Your Mouth

Suboxone is most familiar as a thin film, or strip, that you place under the tongue (sublingual) or against the inside of the cheek (buccal) and let dissolve. It is not swallowed like a normal pill — swallowing it would waste the medicine, because buprenorphine is absorbed through the lining of the mouth, not the stomach. This transmucosal delivery is the standard way buprenorphine is given for opioid use disorder[7].

A few practical things people notice: the film has a distinct, often bitter taste, it takes several minutes to dissolve fully, and you shouldn’t talk, eat, or drink while it’s dissolving. Don’t chew or swallow it. The same buprenorphine-naloxone combination also comes as a sublingual tablet, which works the same way[8]. Once the film is gone and you’ve held off for a few minutes, you can rinse and carry on with your day.

Precipitated Withdrawal and Why Timing the First Dose Matters

What precipitated withdrawal meansPrecipitated withdrawal is withdrawal that the first dose of buprenorphine itself sets off — not the natural withdrawal of stopping opioids, but a sudden, sharp version triggered by starting too soon. It is uncomfortable and frightening, but it is not dangerous in the way an overdose is, and it is preventable.

This is the single most-searched Suboxone fear, so here’s the plain answer. Precipitated withdrawal is real, it’s the reason there’s a rule about when to take your first dose, and when the timing is done right, it is usually avoided entirely[4].

Why the First Dose Can Backfire if You Start Too Soon

Buprenorphine binds to the same brain receptors as other opioids, and it binds very tightly. If full-agonist opioids like heroin, oxycodone, or fentanyl are still occupying those receptors when you take buprenorphine, it shoves them off and replaces a strong signal with a weaker one — and the body reads that sudden drop as withdrawal. Because buprenorphine is displacing a full agonist, this can happen with a standard first dose if it’s taken too early[9].

That is the whole reason for the timing rule. The fear is reasonable; the solution is just as concrete.

You Start When You’re Already in Mild-to-Moderate Withdrawal

The standard approach asks you to be in opioid withdrawal before the first dose, not after[10]. That feels backwards, but it’s protective: once enough of the old opioid has cleared your receptors, buprenorphine has room to bind without knocking anything off, and it relieves withdrawal instead of triggering it.

Precipitated withdrawal is rarer than its reputationThe fear is louder than the event. A systematic review found a low rate of precipitated withdrawal during buprenorphine starts — even among people who use fentanyl — and the takeaway from the field is that evidence, not fear, should guide the decision to start[4][14].

If it does happen, precipitated withdrawal looks like a fast, intense version of ordinary opioid withdrawal — surging anxiety, nausea, sweating, body aches, and agitation coming on within an hour or two of the dose[12]. It is miserable, but it is treatable and it passes.

Clinicians don’t guess at this. They use the Clinical Opiate Withdrawal Scale (COWS) — a quick checklist of signs like sweating, restlessness, gooseflesh, and a fast pulse — to confirm you’re far enough along. Emergency departments and clinics that start buprenorphine typically wait for a COWS score of about 4 or higher before the first dose[11]. The standard induction then builds the dose up over a day or two under guidance[2].

What to know The standard Suboxone start
When to take the first dose Once you’re in mild-to-moderate withdrawal, not before[10]
How that’s confirmed A COWS score around 4 or higher[11]
How the dose is reached Built up over roughly two days, under a clinician’s guidance[2]
If you can’t tolerate waiting Ask about low-dose or micro-induction, which avoids the withdrawal wait[9]

What Precipitated Withdrawal Feels Like and How It’s Handled

Clinicians manage it actively rather than waiting it out. The main strategies are supportive comfort medications and, often, more buprenorphine to fully occupy the receptors and settle the storm, the counterintuitive move that resolves it[13]. This is exactly the kind of thing that goes far better with a medical team than alone, which is the whole argument for starting in a supervised setting.

If Waiting in Withdrawal Isn’t Workable, There’s Another Way

For people who can’t face the withdrawal wait — or who use fentanyl, which lingers in the body and complicates timing — there’s a second route. Low-dose initiation — also called micro-induction or microdosing — starts with tiny amounts of buprenorphine while the other opioid is still on board, then builds up slowly, so the receptors change over gradually instead of all at once. This avoids the withdrawal-first requirement and lowers the risk of precipitated withdrawal[9][10]. It’s been used successfully for the buprenorphine-naloxone combination in hospital settings[15]. If the standard start sounds impossible, this is a real option worth asking about.

Suboxone Versus Subutex and Who Gets Which

People often hear two brand names and assume they’re different drugs. They’re nearly the same — the difference is the second ingredient.

Suboxone is buprenorphine plus naloxone. Subutex is buprenorphine alone[16]. Because the naloxone in Suboxone is mostly inert when taken correctly, the two perform almost identically as treatment — the combination just adds the misuse deterrent. For most people, the combination product is the default first-line choice[1].

The clearest case for the buprenorphine-only form is pregnancy. Buprenorphine is a recommended treatment for opioid use disorder during pregnancy, and historically the mono-product (Subutex) was preferred to avoid exposing the fetus to naloxone[16]. That said, the evidence gap is narrowing: a recent review comparing the combination against buprenorphine alone in pregnancy found broadly comparable gestational and neonatal outcomes, so the choice is increasingly individualized with your obstetric and addiction team rather than automatic[3].

Suboxone Subutex Methadone
What’s in it Buprenorphine + naloxone Buprenorphine alone Methadone (full agonist)
Type of opioid Partial agonist Partial agonist Full agonist
Where you get it Office, primary care, telehealth[5] Office or clinic Licensed opioid treatment program
Often chosen for Most people, first-line[1] Pregnancy, naloxone sensitivity[16] Severe use, high fentanyl exposure

Methadone is the other main medication for opioid use disorder, and it’s a fuller, stronger opioid given through licensed programs. The two are both effective, with real trade-offs in safety, access, and who they suit best[17]. To weigh them head to head, compare Suboxone and methadone →.

Staying on Suboxone and How People Taper Off

Staying on Suboxone is treatment working, not failingBeing stable on Suboxone for a long time is not a sign you haven’t recovered. It’s a sign the treatment is doing its job. Like staying on medication for blood pressure or diabetes, steady maintenance is success, not a step you’ve failed to finish.

Once you’re past the start, Suboxone settles into something quiet and unremarkable — which is exactly the point. The crisis fades into a daily medicine and a life that has room in it again.

Maintenance Is the Goal, and It Can Last as Long as It Helps

Most people do best staying on buprenorphine for the long term — that’s maintenance, and it’s protective. The dose is set to the level that holds cravings and withdrawal at bay, and effective maintenance doses vary from person to person, with some needing higher daily amounts, particularly in the era of fentanyl[18]. There is no fixed finish line. Staying on it for months or years is normal and tied to better outcomes; coming off too soon is one of the most common ways people relapse.

Tapering off Is Possible, Slowly and with Support

Ask your prescriber about your timelineTwo questions worth raising once you’re stable: is this still the dose that’s keeping me steady, and — when life feels solid — what would a slow, supported taper actually look like for me? There’s no rush, and asking early is a sign of doing this well.

Plenty of people eventually want to stop the medication entirely, and that’s a reasonable goal to work toward when life is stable. The way to do it is gradually, under medical supervision, stepping the dose down over time rather than stopping abruptly. In real-world primary care, patients do voluntarily taper off buprenorphine — and, importantly, those who run into trouble can return to maintenance, which is a safety net, not a failure[19]. The path off is real, it’s unhurried, and the door back stays open.

How to Get Suboxone Now

Access has changed for the better. The biggest barrier — a special federal permission that prescribers used to need — is gone.

A Regular Doctor Can Prescribe It

Getting Suboxone is easier than it used to beThe hardest part of getting on Suboxone used to be finding someone allowed to prescribe it. That’s largely solved. A regular doctor, an ER visit, or a telehealth appointment can all be the starting point — the medicine is far more reachable than its reputation suggests.

For years, clinicians needed a special “X-waiver” to prescribe buprenorphine, which kept the number of providers low. That requirement was removed. Today, buprenorphine can be prescribed in ordinary office-based and primary care settings, and health systems are actively working to make it available through regular clinics rather than only specialty programs[5]. A family doctor, an internist, or an addiction provider can start you.

Suboxone is also commonly started in the emergency department — a visit for an overdose or withdrawal can become the moment treatment begins, which is now an evidence-based practice[2]. And it’s increasingly available by telehealth: rules loosened so that buprenorphine induction, maintenance, and counseling can happen by video, which has expanded access and helped people stay in treatment, especially where in-person care is hard to reach[20].

Cost and Insurance, Briefly

Suboxone and generic buprenorphine-naloxone are covered by most insurance plans, including Medicaid and Medicare, and a generic version keeps the out-of-pocket cost manageable for many people. Because it’s now prescribed in regular medical settings, you typically pay a normal office copay plus the pharmacy cost of the medication rather than specialty-clinic fees. If cost is a worry, say so when you call — treatment programs are used to the question, and confidential help can point you to options.

Suboxone Is Safer than the Drugs It Replaces, with One Real Rule

It’s worth ending on the reassurance, because fear keeps people from a treatment that saves lives. Suboxone is an opioid, but it is a far gentler and safer one than heroin, fentanyl, or oxycodone — and getting on it dramatically lowers the danger you’re living with[2].

The partial-agonist design gives buprenorphine a built-in safety ceiling that full opioids don’t have, which is a big part of why it reduces overdose deaths; that mechanism is covered in full alongside how buprenorphine protects you →. The one rule that still matters: do not combine Suboxone with benzodiazepines or alcohol. Each of those slows breathing on its own, and stacking them with any opioid — even a safer one — is where the real risk lives. Keep naloxone on hand, don’t use other sedatives alongside it, and the medicine does what it’s meant to: hold the danger down while you rebuild.

If opioids have taken more of your life than you ever meant to give, here’s the part to hold onto. This is a treatable condition, the treatment works, and the way onto it is more open than it’s ever been. A medication that quiets the cravings, a first dose timed so it goes smoothly, and a life with room in it again — that’s the offer on the table, and it’s a good one. For another path that uses a non-opioid blocker instead, look at naltrexone →, and whenever you’re ready, find treatment that fits your life →.

The next step doesn’t have to be a big one. You can find treatment now and get matched with someone who can help you find the right care and take the next step. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

What is Suboxone and what is it used for?

Suboxone is a brand-name combination of buprenorphine and naloxone, taken as a film or tablet that dissolves under the tongue, and it is used to treat opioid use disorder[1]. The buprenorphine is the active medicine that eases cravings and withdrawal; the naloxone is added only to deter misuse. It is a first-line treatment that reduces illicit opioid use, overdose, and the risk of dying[2].

What does the naloxone in Suboxone do?

When Suboxone is taken correctly under the tongue, the naloxone is poorly absorbed and has little effect, so it does not interfere with treatment[3]. Its only job is to discourage misuse: if someone dissolves and injects the strip, the naloxone becomes active and can trigger withdrawal, which removes the appeal of shooting it. That built-in deterrent is part of why the combination is favored as a first-line, take-home medication[6].

Why do I have to be in withdrawal before my first dose of Suboxone?

Because buprenorphine binds tightly to opioid receptors, if full-agonist opioids are still on those receptors when you take it, it can knock them off and set off sudden withdrawal, called precipitated withdrawal[9]. Waiting until you’re already in mild-to-moderate withdrawal gives the medicine room to bind and relieve symptoms instead of triggering them. Clinicians confirm the timing with the Clinical Opiate Withdrawal Scale, usually waiting for a score of about 4 or higher[11].

How likely is precipitated withdrawal on Suboxone?

Far less likely than its reputation suggests. A systematic review found a low rate of precipitated withdrawal during buprenorphine starts, even among people who use fentanyl, and the message from the field is that evidence, not fear, should guide the decision to start[4][14]. If it does happen, it is managed with comfort medications and often more buprenorphine to settle the receptors[13]. People who can’t tolerate the withdrawal wait can ask about low-dose initiation, which avoids it[9].

What's the difference between Suboxone and Subutex?

Suboxone is buprenorphine plus naloxone; Subutex is buprenorphine alone[16]. Because the naloxone is mostly inert when taken correctly, the two work almost identically as treatment, and the combination is the usual first-line choice[1]. The buprenorphine-only form has historically been preferred in pregnancy to avoid naloxone exposure, though recent evidence finds broadly comparable outcomes, so the choice is increasingly individualized[3].

Do I need a special clinic to get Suboxone?

No. The federal X-waiver that prescribers once needed has been removed, and buprenorphine can now be prescribed in ordinary office-based and primary care settings[5]. It is also commonly started in the emergency department and is increasingly available by telehealth, which has expanded access and helped people stay in treatment[2][20].

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

20 Sources
  1. Wong JSH, Nikoo M, Westenberg JN, Suen JG, Wong JYC, Krausz RM, et al. (2021). Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial. Addiction science & clinical practice. https://doi.org/10.1186/s13722-021-00220-2
  2. Hearrell A, Quincy B (2025). Managing opioid withdrawal in the ED: Best practices for buprenorphine induction. JAAPA : official journal of the American Academy of Physician Assistants. https://doi.org/10.1097/01.jaa.0000000000000283
  3. de Lima FR, Molino GOG, Gallo Ruelas M, Barbosa EC, Silva PHCMd, Guimarães FBdM, et al. (2025). Buprenorphine-naloxone versus buprenorphine for opioid use disorder during pregnancy: A systematic review and meta-analysis. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2025.112632
  4. Gregory C, Yadav K, Linders J, Sikora L, Eagles D (2025). Incidence of buprenorphine-precipitated opioid withdrawal in adults with opioid use disorder: A systematic review. Addiction (Abingdon, England). https://doi.org/10.1111/add.16646
  5. Lott A, Danner AN, Malte CA, Salameh HA, Bachowski D, Gordon AJ, et al. (2025). Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis. Addiction science & clinical practice. https://doi.org/10.1186/s13722-025-00568-9
  6. Hamata B, Griesdale D, Hann J, Rezazadeh-Azar P (2020). Rapid Micro-induction of Buprenorphine/Naloxone for Opioid Use Disorder in a Critically ill Intubated Patient: A Case Report. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000000675
  7. Kabra M, Srivastava T, Gautam R, Singh J, Oksanen J, MacDonald T, et al. (2026). Effectiveness and safety of therapies for patients with opioid use disorder: a systematic review and network meta-analysis. Journal of comparative effectiveness research. https://doi.org/10.57264/cer-2025-0171
  8. Ulu E, Kandeğer A, Meriç R (2022). The use of buprenorphine + naloxone sublingual tablet in the treatment of neonatal opioid withdrawal syndrome: Two case reports. Journal of addictive diseases. https://doi.org/10.1080/10550887.2021.1987784
  9. Edinoff AN, Fahmy OH, Spillers NJ, Zaheri AR, Jackson ED, De Witt AJ, et al. (2023). Low-Dose Initiation of Buprenorphine: A Narrative Review. Current pain and headache reports. https://doi.org/10.1007/s11916-023-01116-3
  10. Moe J, Doyle-Waters MM, O'Sullivan F, Hohl CM, Azar P (2020). Effectiveness of micro-induction approaches to buprenorphine initiation: A systematic review protocol. Addictive behaviors. https://doi.org/10.1016/j.addbeh.2020.106551
  11. D'Onofrio G, Herring AA, Hawk KF, Perrone J, Cowan E, McCormack RP, et al. (2026). Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2025.27019
  12. Spadaro A, Faude S, Perrone J, Thakrar AP, Lowenstein M, Delgado MK, et al. (2023). Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series. Journal of the American College of Emergency Physicians open. https://doi.org/10.1002/emp2.12880
  13. Roberts E, Kalk N, Strang J (2026). Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review. Addiction (Abingdon, England). https://doi.org/10.1111/add.70334
  14. Springer SA (2025). Commentary on Gregory et al.: Fear of precipitated opioid withdrawal should not prevent buprenorphine initiation. Addiction (Abingdon, England). https://doi.org/10.1111/add.16701
  15. Nunn R, Sylvestre A, Sequeira K, Tanzini RM (2024). Buprenorphine/naloxone micro-induction in a tertiary care hospital: a retrospective cohort analysis. Journal of addictive diseases. https://doi.org/10.1080/10550887.2023.2229609
  16. Tith S, Bining G, Bollag L (2018). Management of eight labor and delivery patients dependent on buprenorphine (Subutex™): A retrospective chart review. F1000Research. https://doi.org/10.12688/f1000research.13350.2
  17. Degenhardt L, Clark B, Macpherson G, Leppan O, Nielsen S, Zahra E, et al. (2023). Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The lancet. Psychiatry. https://doi.org/10.1016/s2215-0366(23)00095-0
  18. Sabol RM, Mayrer BM, Anderson TS, Shuey B, Roy P, Suda KJ, et al. (2026). Trends and geographic disparities in maintenance dose of buprenorphine for opioid use disorder: A cross-sectional pharmacy claims analysis. Journal of substance use and addiction treatment. https://doi.org/10.1016/j.josat.2026.209986
  19. Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, et al. (2018). Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2018.05.010
  20. Aronowitz SV, Zucker N, Thompson M, James R, Clapp J, Mandell D (2025). Patient and provider experiences with opioid use disorder care delivered via telehealth: A systematic mixed-studies review. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2024.112522
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.